GNFT (Genfit S.A.) קצב צמיחת רווח למניה בשנה הנוכחית

The future pricing power of Genfit S.A. (GNFT) relies on the success of clinical trials in niche markets. The net income per share growth rate compared to last year confirms this trend, with the indicator holding at -720.00. Pipeline diversification across rare liver pathologies mitigates risks, while independence from macroeconomic factors transforms the asset into a reliable defensive tool.
פילוחים אנליטיים ודוחות נתונים של חברת Genfit S.A. (GNFT)

This indicator measures the annual dynamics of net profit per share, reflecting management's ability to generate income per ownership stake. By analyzing the annual variation in EPS, an investor can discern capital sensitivity to operational shocks, which is critical for Genfit S.A. (GNFT) due to liquidity shortages and the uncertain outcomes of clinical trials for liver pathology drugs.